Lung cancer remains the leading cause of cancer death worldwide. According to the World Health Organization, lung cancer was responsible for 1.8 million deaths — 18% of cancer deaths — in 2020 alone.
As a middle school math teacher in Woodbridge, Virginia, Dr. Arik King saw firsthand how boys of color trailed their peers in test scores, attendance, and graduation rates—part of an alarming and persistent national trend.
Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim's oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.
Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for oncology testing. The partnership is intended to advance the use of next-generation sequencing (NGS) for decentralized oncology testing and aligns with Illumina's approach to IVD partnerships in oncology. Agendia joins Illumina's growing portfolio of more than 30 IVD partners developing over 40 sequencing-based solutions for cancer prognosis, therapy selection and other applications.
Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource. Using Illumina's next-generation sequencing (NGS) platforms, scientists and researchers will be able to better identify disease associations and targets for intervention by analyzing data derived from VUMC's extensive, high-quality biobank of approximately 250,000 de-identified human DNA samples and associated longitudinal, structured medical data.
Illumina, Inc. (NASDAQ:ILMN) Chief Executive Officer, Francis deSouza, discussed the company's strong growth trajectory, including 2021 results and 2022 guidance. deSouza also announced new partnerships and technologies that will advance the company's mission of improving human health by unlocking the power of the genome.
In celebration of National Blood Donor Month AEG’s LA Kings and the Kings Care Foundation recently kicked off its blood drive series in conjunction with Children’s Hospital Los Angeles (CHLA) at Crypto.com Arena (formerly STAPLES Center).
Through the partnership, the restaurant giant is hoping to attract customers who are eating less meat but may not want to follow strict vegetarian or vegan diets.
In a recent TEDxOshkosh talk, Kimberly-Clark’s chief scientist Pete Dulcamara discussed how a new focus on humanity-centric innovation can help solve the most significant problems facing society and the environment.
The fully autonomous vehicles of the not-so-distant future promise tremendous gains in automotive safety and transportation efficiency. But to fulfill this promise, automotive OEMs must move beyond contemporary levels of vehicle autonomy.
Entergy’s 2025 performance report, “Energy for a better future” presents an overview of our company’s 2025 achievements, future plans and strategies...
Antea Group's health and safety consultants understand what it takes to help make a positive impact on safety culture. Read blogs, insights, and more...
AEG embraces its responsibility to enrich the lives of people in the communities around the world where we do business, and to use business to create...
From the frontline to the back office, every Chemours employee knows they are a part of something bigger than themselves and are proud to be a part of...
Focus on preventing and treating malnutrition across life stages. Highlights include early detection, community-based treatment (e.g., MUAC screening...
Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...
